418 related articles for article (PubMed ID: 33034417)
1. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
2. Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.
Neilan AM; Karalius B; Patel K; Van Dyke RB; Abzug MJ; Agwu AL; Williams PL; Purswani M; Kacanek D; Oleske JM; Burchett SK; Wiznia A; Chernoff M; Seage GR; Ciaranello AL;
JAMA Pediatr; 2017 May; 171(5):450-460. PubMed ID: 28346597
[TBL] [Abstract][Full Text] [Related]
3. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration.
Kariminia A; Law M; Davies MA; Vinikoor M; Wools-Kaloustian K; Leroy V; Edmonds A; McGowan C; Vreeman R; Fairlie L; Ayaya S; Yotebieng M; Takassi E; Pinto J; Adedimeji A; Malateste K; Machado DM; Penazzato M; Hazra R; Sohn AH;
J Int AIDS Soc; 2018 Dec; 21(12):e25215. PubMed ID: 30548817
[TBL] [Abstract][Full Text] [Related]
4. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
5. Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium.
Jesson J; Desmonde S; Yiannoutsos CT; Patten G; Malateste K; Duda SN; Kumarasamy N; Yotebieng M; Davies MA; Musick B; Leroy V; Ciaranello A;
BMC Res Notes; 2020 May; 13(1):249. PubMed ID: 32448379
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
Leroy V; Malateste K; Rabie H; Lumbiganon P; Ayaya S; Dicko F; Davies MA; Kariminia A; Wools-Kaloustian K; Aka E; Phiri S; Aurpibul L; Yiannoutsos C; Signaté-Sy H; Mofenson L; Dabis F;
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):208-19. PubMed ID: 23187940
[TBL] [Abstract][Full Text] [Related]
7. Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regional analysis.
Ciaranello A; Lu Z; Ayaya S; Losina E; Musick B; Vreeman R; Freedberg KA; Abrams EJ; Dillabaugh L; Doherty K; Ssali J; Yiannoutsos CT; Wools-Kaloustian K
Pediatr Infect Dis J; 2014 Jun; 33(6):623-9. PubMed ID: 24378935
[TBL] [Abstract][Full Text] [Related]
8. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.
Panayidou K; Davies MA; Anderegg N; Egger M;
J Int AIDS Soc; 2018 Nov; 21(11):e25200. PubMed ID: 30614622
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.
; Slogrove AL; Schomaker M; Davies MA; Williams P; Balkan S; Ben-Farhat J; Calles N; Chokephaibulkit K; Duff C; Eboua TF; Kekitiinwa-Rukyalekere A; Maxwell N; Pinto J; Seage G; Teasdale CA; Wanless S; Warszawski J; Wools-Kaloustian K; Yotebieng M; Timmerman V; Collins IJ; Goodall R; Smith C; Patel K; Paul M; Gibb D; Vreeman R; Abrams EJ; Hazra R; Van Dyke R; Bekker LG; Mofenson L; Vicari M; Essajee S; Penazzato M; Anabwani G; Q Mohapi E; N Kazembe P; Hlatshwayo M; Lumumba M; Goetghebuer T; Thorne C; Galli L; van Rossum A; Giaquinto C; Marczynska M; Marques L; Prata F; Ene L; Okhonskaia L; Rojo P; Fortuny C; Naver L; Rudin C; Le Coeur S; Volokha A; Rouzier V; Succi R; Sohn A; Kariminia A; Edmonds A; Lelo P; Ayaya S; Ongwen P; Jefferys LF; Phiri S; Mubiana-Mbewe M; Sawry S; Renner L; Sylla M; Abzug MJ; Levin M; Oleske J; Chernoff M; Traite S; Purswani M; Chadwick EG; Judd A; Leroy V
PLoS Med; 2018 Mar; 15(3):e1002514. PubMed ID: 29494593
[TBL] [Abstract][Full Text] [Related]
10. Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration.
Jesson J; Schomaker M; Malasteste K; Wati DK; Kariminia A; Sylla M; Kouadio K; Sawry S; Mubiana-Mbewe M; Ayaya S; Vreeman R; McGowan CC; Yotebieng M; Leroy V; Davies MA;
J Int AIDS Soc; 2019 Nov; 22(11):e25412. PubMed ID: 31702088
[TBL] [Abstract][Full Text] [Related]
11. Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus nonperinatally acquired HIV.
Desmonde S; Ciaranello AL; Malateste K; Musick B; Patten G; Vu AT; Edmonds A; Neilan AM; Duda SN; Wools-Kaloustian K; Davies MA; Leroy V;
AIDS; 2021 Mar; 35(4):625-632. PubMed ID: 33252479
[TBL] [Abstract][Full Text] [Related]
12. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
[TBL] [Abstract][Full Text] [Related]
13. Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration.
Kassanjee R; Johnson LF; Zaniewski E; Ballif M; Christ B; Yiannoutsos CT; Nyakato P; Desmonde S; Edmonds A; Sudjaritruk T; Pinto J; Vreeman R; Dahourou DL; Twizere C; Kariminia A; Carlucci JG; Kasozi C; Davies MA;
J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25780. PubMed ID: 34546646
[TBL] [Abstract][Full Text] [Related]
14. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network.
Wolff M; Shepherd BE; Cortés C; Rebeiro P; Cesar C; Wagner Cardoso S; Pape JW; Padgett D; Sierra-Madero J; Echevarria J; McGowan CC;
J Acquir Immune Defic Syndr; 2016 Jan; 71(1):102-10. PubMed ID: 26761273
[TBL] [Abstract][Full Text] [Related]
16. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
Gabillard D; Lewden C; Ndoye I; Moh R; Segeral O; Tonwe-Gold B; Etard JF; Pagnaroat M; Fournier-Nicolle I; Eholié S; Konate I; Minga A; Mpoudi-Ngole E; Koulla-Shiro S; Zannou DM; Anglaret X; Laurent C;
J Acquir Immune Defic Syndr; 2013 Apr; 62(5):555-61. PubMed ID: 23274931
[TBL] [Abstract][Full Text] [Related]
17. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.
Schomaker M; Leroy V; Wolfs T; Technau KG; Renner L; Judd A; Sawry S; Amorissani-Folquet M; Noguera-Julian A; Tanser F; Eboua F; Navarro ML; Chimbetete C; Amani-Bosse C; Warszawski J; Phiri S; N'Gbeche S; Cox V; Koueta F; Giddy J; Sygnaté-Sy H; Raben D; Chêne G; Davies MA;
Int J Epidemiol; 2017 Apr; 46(2):453-465. PubMed ID: 27342220
[TBL] [Abstract][Full Text] [Related]
18. Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA).
Giles ML; Achhra AC; Abraham AG; Haas AD; Gill MJ; Lee MP; Luque M; McGowan C; Cornell M; Braitstein P; de Rekeneire N; Becquet R; Wools-Kaloustian K; Law M
J Int AIDS Soc; 2018 Jun; 21(6):e25149. PubMed ID: 29956882
[TBL] [Abstract][Full Text] [Related]
19. Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis.
Seyler C; Messou E; Gabillard D; Inwoley A; Alioum A; Anglaret X
AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1338-47. PubMed ID: 18184075
[TBL] [Abstract][Full Text] [Related]
20. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis.
; Jesson J; Crichton S; Quartagno M; Yotebieng M; Abrams EJ; Chokephaibulkit K; Le Coeur S; Aké-Assi MH; Patel K; Pinto J; Paul M; Vreeman R; Davies MA; Ben-Farhat J; Van Dyke R; Judd A; Mofenson L; Vicari M; Seage G; Bekker LG; Essajee S; Gibb D; Penazzato M; Collins IJ; Wools-Kaloustian K; Slogrove A; Powis K; Williams P; Matshaba M; Thahane L; Nyasulu P; Lukhele B; Mwita L; Kekitiinwa-Rukyalekere A; Wanless S; Goetghebuer T; Thorne C; Warszawski J; Galli L; van Rossum AMC; Giaquinto C; Marczynska M; Marques L; Prata F; Ene L; Okhonskaya L; Navarro M; Frick A; Naver L; Kahlert C; Volokha A; Chappell E; Pape JW; Rouzier V; Marcelin A; Succi R; Sohn AH; Kariminia A; Edmonds A; Lelo P; Lyamuya R; Ogalo EA; Odhiambo FA; Haas AD; Bolton C; Muhairwe J; Tweya H; Sylla M; D'Almeida M; Renner L; Abzug MJ; Oleske J; Purswani M; Teasdale C; Nuwagaba-Biribonwoha H; Goodall R; Leroy V
J Int AIDS Soc; 2022 Mar; 25(3):e25871. PubMed ID: 35255197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
